Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.